COMMUNIQUÉS West-GlobeNewswire

ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights
05/08/2019
-- Topline data from pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis on track for Q4 2019 -- -- Completed enrollment in LUMINA 1 Phase II trial of CCR2 inhibitor CCX140 in Focal [...]
Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
05/08/2019
Continued enrollment and dose escalation of Phase 1 trial for HPN424, Harpoon’s lead TriTAC product candidate in development for the treatment of prostate cancer Initiated Phase 1/2a clinical trial for HPN536, Harpoon’s [...]
Shockwave Medical Reports Second Quarter 2019 Financial Results
05/08/2019
SANTA CLARA, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Entasis Therapeutics Appoints Dr. Howard Mayer to Board of Directors
05/08/2019
WALTHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Radius Health Initiates Phase 3 wearABLe Study of Abaloparatide-Patch in Postmenopausal Osteoporosis Patients at High Risk for Fracture
05/08/2019
Abaloparatide-Patch patient assessment study results demonstrated high patient acceptability and self-administration accuracy over a 29-day period Levels of PINP, a biomarker for bone formation, after one month in [...]
United Health Products Announces the Completion of Human Trial Surgery Enrollment
05/08/2019
HENDERSON, Nev., Aug. 05, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound [...]
Opthea to Host Investor Teleconference
05/08/2019
MELBOURNE, Australia, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT) will host a conference call to discuss the results of the Company’s Phase 2b clinical trial of OPT-302 in combination with Lucentis ® ( [...]
Major shareholder announcement
05/08/2019
Company announcement No. 24/2019 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 Copenhagen, August 5, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated [...]
Corizon Health Chosen to Continue Services for Fayette County, Kentucky
05/08/2019
BRENTWOOD, Tenn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Corizon Health recently won a competitive bidding process to continue providing medical services for offenders in the Community Corrections Center operated by the [...]
Dr. Gary Kaplan to Present Keynote at The Governance Institute’s October Leadership Conference
05/08/2019
Influential physician executive and healthcare leader will challenge boards with improving quality, safety, and efficiency LINCOLN, Neb., Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Governance Institute , a service of NRC [...]
BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer
05/08/2019
MALVERN, Pa., Aug. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2019
05/08/2019
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2019
05/08/2019
Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]
Transactions under Novozymes’ stock buyback program
05/08/2019
Please read the full announcement in the attached PDF Attachment 2019_26_Stock_Buybackprogram_EN
CyberFuels, Inc. Launches Sales of its Specially Formulated EcoFlex 91 and 93 Octane GEM fuels in Daytona Beach Florida
05/08/2019
PALM BEACH GARDENS, Fla., Aug. 05, 2019 (GLOBE NEWSWIRE) -- EncounterCare Solutions (ECSL Pink Sheets OTC) is pleased to announce that its subsidiary CyberFuels Inc. is now offering its specially formulated EcoFlex 91 [...]
Notable Named To Fast Company’s Inaugural List Of The 50 Best Workplaces for Innovators
05/08/2019
Notable joins Amazon, Chobani, L’Oréal, Morgan Stanley, P&G, and other leading companies to top the list SAN FRANCISCO, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Notable , which is redefining cancer treatment with a [...]
LipoMedix Appoints New Members to Board of Directors and Creates New Executive Committee
05/08/2019
Jerusalem, Aug. 05, 2019 (GLOBE NEWSWIRE) -- LipoMedix Pharmaceuticals Ltd. , a clinical and development-stage company focused on the development of an innovative, safe and effective cancer therapy based on liposome [...]
Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
05/08/2019
REDWOOD CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “Company”) (OTCQB:RZLT), today announced that senior management will present at the 2019 Canaccord Genuity Growth Conference in [...]
Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives
05/08/2019
WESTLAKE VILLAGE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has retained Cowen as an [...]

Pages